Last Updated: May 11, 2026

Claims for Patent: 5,900,488

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,900,488

Title:	Method for treating mycosis using imidazolylacetonitrile derivatives
Abstract:	PCT No. PCT/JP96/01872 Sec. 371 Date Dec. 31, 1997 Sec. 102(e) Date Dec. 31, 1997 PCT Filed Jul. 5, 1996 PCT Pub. No. WO97/02821 PCT Pub. Date Jan. 30, 1997R-(+)-(E)-[4-(2-Chlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolylacetonitrile, R-(-)-(E)-[4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolylacetonitrile, and pharmaceutically acceptable salts thereof which can be used as a pharmaceutical agent are disclosed. A process for producing them and a method for treating mycoses using them are also disclosed.
Inventor(s):	Hiroki Kodama, Yoshimi Niwano, Kazuo Kanai, Masanori Yoshida
Assignee:	Nihon Nohyaku Co Ltd
Application Number:	US08/981,420
Patent Claims:	1. R-(-)-(E)- 4-(2,4-Dichlorophenyl)-1,3-dithilan-2-ylidene!-1-imidazolylacetonitrile or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising as an active ingredient R-(-)-(E)- 4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene!-1-imidazolylacetonitrile, or a pharmaceutically acceptable salt thereof; together with a pharmaceutically acceptable carrier or diluent. 3. A process for producing R-(-)-(E)- 4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene!-1-imidazolylacetonitrile represented by formula (B): ##STR16## which comprises reacting an optically active glycol derivative represented by formula (II) with a dithiolate salt represented by formula (III): ##STR17## wherein X1 and X2 are the same or different and each represents a methanesulfonyloxy group, a benzenesulfonyloxy group, a p-toluenesulfonyloxy group, or a halogen atom: ##STR18## wherein M represents an alkali metal atom. 4. A method for preventing or treating mycosis which comprises administrating to a human or animal in need of such prevention or treatment, a pharmaceutically effective amount of R-(-)-(E)- 4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene!-1-imidazolylacetonitrile, or a pharmaceutical acceptable salt thereof.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.